Search - tctmd.com

Displaying 61 - 80 of 109

Sort: Relevancy | Date

Presentation TCT 2017

CASE #4: Asymptomatic Atherosclerotic Obstruction in the Brachial Artery (With Discussion)

Presenter: James Nolan, Christopher Pyne, Paul Gordon

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Allan Schwartz

October 30, 2017

Presentation TCT 2017

Expanding TAVR Indications (Heart Failure, Asymptomatic Severe AS, and Aortic Regurgitation)

Presenter: Jeroen J. Bax, Axel Linke, Nicolas M. Van Mieghem

October 29, 2017

Presentation TVT 2017

Rationale and Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Presenter: David J. Cohen, Jeffrey J. Popma, Philippe Généreux

June 16, 2017

Presentation ECHO 2017

The Role of Echo in the Management of Asymptomatic Disease

Presenter: Philippe Pibarot

April 01, 2017

Presentation TCT 2016

Twelve-Month Safety and Efficacy of CGuard Micro-Net-Covered Embolic Prevention System: Routine Use to Perform Carotid Revascularization in Symptomatic and Increased Stroke Risk Asymptomatic Patients: The PARADIGM All-Comer Prospective Study

Presenter: Robert M. Bersin, John R. Laird Jr., Piotr Musialek

November 01, 2016

Presentation TCT 2016

Trial #8 - The Essentials ofThe ACT I Trial: Carotid Stenting vs Surgery In Asymptomatic Patients

Presenter: William A. Gray, Stephan Windecker, Kenneth Rosenfield

October 31, 2016

Presentation TCT 2016

Severe Asymptomatic AS

Presenter: Jean-Claude Laborde, Wilson Y. Szeto, Philippe Généreux

October 31, 2016

Presentation TVT 2016

The Case for Accelerating Therapy in Patients With Asymptomatic Severe AS

Presenter: Philippe Généreux

June 17, 2016

Presentation ECHO 2016

Asymptomatic Valvular Heart Disease: Can Echocardiography Help with Decision-Making?

Presenter: Charles J. Bruce

March 22, 2016

Presentation TCT 2015

Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

Presenter: John D. Carroll, Ioanna Kosmidou, Tomohiko Taniguchi

October 15, 2015

Presentation TCT 2015

Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

Presenter: Tomohiko Taniguchi

October 15, 2015

Presentation TCT 2015

Special Lecture: Systematic Review on Management Strategies for Asymptomatic Severe AS

Presenter: D. Craig Miller, Alec S. Vahanian, Philippe Généreux

October 12, 2015

Presentation TCT 2015

Severe Asymptomatic Aortic Stenosis: Thoughtful Commentary on the Case

Presenter: Robert O. Bonow, Allan Schwartz

October 12, 2015

Presentation TCT 2015

Severe Asymptomatic Aortic Stenosis: Case Presentation

Presenter: Robert O. Bonow, Allan Schwartz, Haim Danenberg

October 12, 2015

Presentation

15-Year Warranty Period for Asymptomatic Individuals Without Coronary Artery Calcium (CAC)

Presenter: V. Valenti

August 05, 2015

Presentation

Long-term Prognosis After Coronary Artery Calcification (CAC) Testing in Asymptomatic Patients

Presenter: Leslee J. Shaw

July 08, 2015

Presentation TVT 2015

Thoughtful Commentary: Severe Asymptomatic AS and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Allan Schwartz

June 04, 2015

Presentation TVT 2015

Case Presentation: Severe Asymptomatic AS and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Vasilis Babaliaros

June 04, 2015

Presentation ECHO 2015

Asymptomatic Aortic and Mitral Disease: The Clinician’s Dilemma

Presenter: Neil J. Weissman

April 27, 2015

Advertisement

CASE #4: Asymptomatic Atherosclerotic Obstruction in the Brachial Artery (With Discussion)

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Expanding TAVR Indications (Heart Failure, Asymptomatic Severe AS, and Aortic Regurgitation)

Rationale and Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

The Role of Echo in the Management of Asymptomatic Disease

Twelve-Month Safety and Efficacy of CGuard Micro-Net-Covered Embolic Prevention System: Routine Use to Perform Carotid Revascularization in Symptomatic and Increased Stroke Risk Asymptomatic Patients: The PARADIGM All-Comer Prospective Study

Trial #8 - The Essentials ofThe ACT I Trial: Carotid Stenting vs Surgery In Asymptomatic Patients

Severe Asymptomatic AS

The Case for Accelerating Therapy in Patients With Asymptomatic Severe AS

Asymptomatic Valvular Heart Disease: Can Echocardiography Help with Decision-Making?

Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

Special Lecture: Systematic Review on Management Strategies for Asymptomatic Severe AS

Severe Asymptomatic Aortic Stenosis: Thoughtful Commentary on the Case

Severe Asymptomatic Aortic Stenosis: Case Presentation

15-Year Warranty Period for Asymptomatic Individuals Without Coronary Artery Calcium (CAC)

Long-term Prognosis After Coronary Artery Calcification (CAC) Testing in Asymptomatic Patients

Thoughtful Commentary: Severe Asymptomatic AS and TAVR

Case Presentation: Severe Asymptomatic AS and TAVR

Asymptomatic Aortic and Mitral Disease: The Clinician’s Dilemma

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content